专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

31. 发明授权

US10781531B2 Method for producing nickel-containing hydroxide 有权
公开(公告)号：US10781531B2
公开(公告)日：2020-09-22
申请号：US16308949
申请日：2017-06-12
申请人： SUMITOMO METAL MINING CO., LTD.
发明人： Shuhei Nakakura , Kazuhiko Tsuchioka , Koichiro Maki , Motoaki Saruwatari , Kazuomi Ryoshi , Yoshihiko Nakao , Masafumi Yoshida
IPC分类号： C30B7/08 , C30B7/14 , C01G53/00 , C01G53/04 , H01M4/32 , H01M4/52 , H01M4/505 , H01M4/525
摘要： A method for producing a nickel-containing hydroxide is provided that includes a nucleation step of generating nuclei of nickel-containing hydroxide particles by neutralization crystallization in an aqueous solution accommodated in an agitation tank. In the nucleation step, a volume fraction of a highly supersaturated region in the aqueous solution where the molar concentration of the nickel-containing hydroxide dissolved in the aqueous solution is greater than or equal to 5.0 mol/m3 is less than 0.100% of the aqueous solution.

32. 发明授权

US10774109B2 Crystal of reduced glutathione and method for producing same 有权
公开(公告)号：US10774109B2
公开(公告)日：2020-09-15
申请号：US16083483
申请日：2017-03-10
申请人： KYOWA HAKKO BIO CO., LTD.
发明人： Kazunari Fukumoto , Maya Iguchi , Hiroshi Nagano
IPC分类号： C07K5/037 , A61K38/06 , A61P1/16 , A61P39/02 , C30B7/08 , C30B29/58 , C07K5/02
摘要： The present invention provides a crystal of reduced glutathione having excellent powder properties and a method for producing the same. The present invention relates to a crystal of reduced glutathione, wherein the average crystal thickness is 10 μm or more.

33. 发明授权

US10461241B2 Method for manufacturing rectangular parallelepiped-shaped single crystal, rectangular parallelepiped-shaped single crystal, method for manufacturing ceramics, ceramics, piezoelectric element, piezoelectric device, and electronic device 有权
公开(公告)号：US10461241B2
公开(公告)日：2019-10-29
申请号：US15070936
申请日：2016-03-15
申请人： CANON KABUSHIKI KAISHA
发明人： Takayuki Watanabe , Shunsuke Murakami , Makoto Kubota
IPC分类号： H01L41/187 , C30B29/30 , C30B7/08 , H01L41/43
摘要： This invention is a method for manufacturing a rectangular parallelepiped-shaped single crystal containing sodium niobate of a perovskite structure as the main component, and the method includes a process of heating a mixture 1 of bismuth sodium niobate which is formed from particles containing a plurality of crystals represented by General Formula (1): Bi2.5Nam−1.5NbmO3m+3 (m is an integer of 2 or more) and in which an average value ma of the m values is larger than 6 and sodium containing alkali metal halide at 1200° C. or more and 1250° C. or less to obtain a rectangular parallelepiped-shaped single crystal containing sodium niobate as the main component.

34. 发明申请

US20180371638A1 METHOD FOR PRODUCING METAL OXIDE NANOCRYSTALS, METHOD FOR PRODUCING MULTI-ELEMENT OXIDE NANOCRYSTALS, AND METAL OXIDE NANOCRYSTALS 审中-公开
公开(公告)号：US20180371638A1
公开(公告)日：2018-12-27
申请号：US15747095
申请日：2016-07-22
申请人： Shoei Chemical Inc.
发明人： Thomas E. Novet , Yukihisa Okawa , Masahito Igari , David M. Schut
IPC分类号： C30B7/08 , C01F17/00 , C01F7/02
摘要： A method for producing metal oxide nanocrystals, according to the embodiment of the present invention, includes: continuously flowing, into a continuous flow path, one or a plurality of nanocrystal precursor solutions each comprising one or more nanocrystal precursors dissolved in a non-polar solvent; directing a segmenting gas into the continuous flow path to create a segmented reaction flow; flowing the segmented reaction flow into a thermal processor; heating the segmented reaction flow in the thermal processor to create a product flow; and collecting metal oxide nanocrystals from the product flow.

35. 发明申请

US20180016156A1 PRODUCTION OF CRYSTALLIZED COBALT (II) CHLORIDE HEXAHYDRATE 审中-公开
公开(公告)号：US20180016156A1
公开(公告)日：2018-01-18
申请号：US15716470
申请日：2017-09-26
申请人： Morteza Enhessari , Ali Salehabadi , Keyvan Ozaee
发明人： Morteza Enhessari , Ali Salehabadi , Keyvan Ozaee
IPC分类号： C01G51/08 , C30B25/14 , B01D9/00 , B01D1/00 , C22B3/00 , B01D24/02 , C30B25/18 , C30B7/08
CPC分类号： C01G51/085 , B01D1/0011 , B01D9/0018 , B01D24/02 , B01D2259/122 , C01P2002/72 , C01P2002/82 , C01P2006/60 , C01P2006/80 , C22B23/0423 , C30B7/08 , C30B25/14 , C30B25/186 , C30B29/12
摘要： A method for production of crystallized Cobalt (II) Chloride hexahydrate is disclosed, and an implementation includes preparing a first cobalt (II) chloride solution, separating impurities from the first cobalt (II) chloride solution to obtain a second cobalt (II) chloride solution, concentrating the second cobalt (II) chloride solution, cooling the concentrated second cobalt (II) chloride solution, and injecting CO2 gas into the cooled concentrated second cobalt (II) chloride solution at an atmospheric pressure in order for Cobalt (II) Chloride hexahydrate crystals to form in the cooled concentrated second cobalt (II) chloride solution.

36. 发明授权

US09850593B2 Method of making quantum dots 有权
公开(公告)号：US09850593B2
公开(公告)日：2017-12-26
申请号：US14284292
申请日：2014-05-21
申请人： SAMSUNG ELECTRONICS CO., LTD
发明人： Wenhao Liu , Craig Breen
IPC分类号： C09K11/88 , C09K11/56 , C09K11/02 , C30B29/48 , C30B7/14 , H01L21/02 , B22F1/00 , B22F1/02 , B22F9/24 , C22C1/10 , C22C20/00 , B82Y30/00 , C30B7/00 , C30B7/08 , C30B19/12 , C30B29/68 , H01L33/28 , B82Y40/00 , B82Y20/00
CPC分类号： C30B7/14 , B22F1/0018 , B22F1/025 , B22F9/24 , B82Y20/00 , B82Y30/00 , B82Y40/00 , C22C1/1026 , C22C20/00 , C30B7/005 , C30B7/08 , C30B19/12 , C30B29/48 , C30B29/68 , H01L21/02557 , H01L21/0256 , H01L21/02601 , H01L21/02628 , H01L33/28 , Y10S977/774 , Y10S977/892 , Y10S977/896 , Y10S977/95
摘要： Quantum dots and methods of making quantum dots are provided.

37. 发明授权

US09606126B2 Compositions and methods for membrane protein detergent stability screen 有权
公开(公告)号：US09606126B2
公开(公告)日：2017-03-28
申请号：US13376729
申请日：2010-06-29
申请人： Michael C. Wiener , James M. Vergis
发明人： Michael C. Wiener , James M. Vergis
IPC分类号： G01N33/68 , C30B7/08 , B01D15/38
CPC分类号： G01N33/6803 , B01D15/3804 , C30B7/08
摘要： The invention provides methods to assess protein stability and to obtain sizing information. In one aspect, the screen comprises a 94 detergent panel and a series of MWCO filtered microplates. A protein of interest is bound to an affinity matrix and aliquoted into a 96-well microplate. Wells containing the immobilized protein are washed in the new detergent and then eluted in the new detergent into a collection plate. Protein not stable in the new detergent is precipitated on the resin and not present in the elutions. Half of the elution is passed through a high (i.e., 300 kDa) MWCO microplate and the other half through a low (i.e., 100 kDa) MWCO microplate. Elutions from the microplates are spotted on a nitrocellulose membrane, visualized by Western analysis (or by some other method), and quantified. The high MWCO provides stability readout and the ratio of low/high kDa provides sizing information.

38. 发明授权

US09598376B2 Preparation of and formulation comprising a MEK inhibitor 有权
公开(公告)号：US09598376B2
公开(公告)日：2017-03-21
申请号：US15053441
申请日：2016-02-25
申请人： Novartis AG , Array BioPharma, Inc.
发明人： Christoph Max Krell , Marian Misun , Daniel Andreas Niederer , Werner Heinz Pachinger , Marie-Christine Wolf , Daniel Zimmermann , Weidong Liu , Peter J. Stengel , Paul Nichols
IPC分类号： C07D235/08 , C07D235/06 , A61K47/26 , A61K47/38 , A61K9/20 , C30B7/08 , C30B29/54 , A61K47/02 , A61K47/12
CPC分类号： A61K31/4184 , A61K9/0053 , A61K9/2009 , A61K9/2013 , A61K9/2018 , A61K9/2054 , A61K45/06 , A61K47/02 , A61K47/12 , A61K47/26 , A61K47/38 , C07B2200/13 , C07D235/06 , C07D235/08 , C30B7/08 , C30B29/54
摘要： The present invention relates to processes for preparing 6-(4-bromo-2-fluorophenylamino)-7-fluoro -3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxyethyoxy)-amide, processes for preparing crystallized 6-(4-bromo-2-fluorophenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxyethyoxy)-amide, and intermediates useful therefore. Also provided herein are pharmaceutical compositions comprising this crystallized compound.

39. 发明授权

US09382639B2 Device and method for crystallizing inorganic or organic substances 有权
标题翻译：用于结晶无机或有机物质的装置和方法
公开(公告)号：US09382639B2
公开(公告)日：2016-07-05
申请号：US13821053
申请日：2011-09-15
申请人： Monika Spano
发明人： Monika Spano
IPC分类号： C30B7/08 , C30B7/00 , C30B29/54 , C30B29/58
CPC分类号： C30B7/08 , C30B7/00 , C30B29/54 , C30B29/58 , Y10T117/1004
摘要： A device for crystallizing a molecule to be crystallized, which includes: at least one crystallization cell that includes a crystallization chamber for receiving a first solution S1 containing the molecule to be crystallized and the crystal seeds thereof, a dialysis membrane, and a container to be filled with a second solution S2 that contains constituents selected from the group containing crystallization agents, additives and buffers; and at least one image acquisition means. The crystallization device is characterized in that it includes: at least one addition means arranged to add, to the container, constituents selected from the group containing crystallization agents, additives and buffers of solution S2; and/or at least one sampling means arranged to collect, from the container, all or a portion of solution S2. The invention also relates to a crystallization method.
摘要翻译：一种用于使待结晶的分子结晶的装置，其包括：至少一个结晶池，其包括用于接收含有待结晶分子的第一溶液S1和其晶种，结晶室，透析膜和容器填充含有选自含结晶剂，添加剂和缓冲剂的组分的成分的第二溶液S2; 和至少一个图像获取装置。结晶装置的特征在于它包括：至少一个添加装置，其被布置成向容器中添加选自含有结晶剂的组的组分，溶液S2的添加剂和缓冲剂; 和/或至少一个采样装置，其被布置成从容器收集溶液S2的全部或一部分。本发明还涉及一种结晶方法。

40. 发明授权

US09382212B1 Preparation of and formulation comprising a MEK inhibitor 有权
公开(公告)号：US09382212B1
公开(公告)日：2016-07-05
申请号：US14974588
申请日：2015-12-18
申请人： Novartis AG , Array BioPharma, Inc.
发明人： Christoph Max Krell , Marian Misun , Daniel Andreas Niederer , Werner Heinz Pachinger , Marie-Christine Wolf , Daniel Zimmermann , Weidong Liu , Peter J. Stengel , Paul Nichols
IPC分类号： C07D235/06 , C30B7/08 , C30B29/54
CPC分类号： A61K31/4184 , A61K9/0053 , A61K9/2009 , A61K9/2013 , A61K9/2018 , A61K9/2054 , A61K45/06 , A61K47/02 , A61K47/12 , A61K47/26 , A61K47/38 , C07B2200/13 , C07D235/06 , C07D235/08 , C30B7/08 , C30B29/54
摘要： The present invention relates to processes for preparing 6-(4-bromo-2-fluorophenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxyethyoxy)-amide, processes for preparing crystallized 6-(4-bromo-2-fluorophenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxyethyoxy)-amide, and intermediates useful therefore. Also provided herein are pharmaceutical compositions comprising this crystallized compound.

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式